Finzati - Logo
SPRC logo

SciSparc Ltd.

SPRC • Biotechnology
$5.29
▲ +0.16 (+3.12%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$214,795.16
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.09Healthy liquidity · 2.41Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Apr 23, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$5.29
Change3.12%
Shares Out40.60K
Market Cap$214.80K
Enterprise Value$-4.02M
52W Range2.98 - 80.10
Beta2.43
P/E-0.01
P/S0.10
P/B0.05
P/FCF-0.02
EV/Sales-1.86

Investment DNA

How strong this company looks for long-term investors

29
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.09Healthy liquidity · 2.41Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/30/2021
Industry: Biotechnology
P/B i: 0.05
Debt / Equity i: 0.09
Operating Margin: -1022.08%
Net Margin: -1422.78%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.09
Current Ratio: 2.41
Quick Ratio: 2.38
Status: Good

Insider Transactions

Recent executive and insider activity

Shrem Itschak
Transaction: 06/01/2026
SELL
Change
-462
Price
$10.00
Filing
06/03/2026
Type
SELL
DAYAN ALON
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/23/2026
Type
OTHER
Sidi Liat
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/18/2026
Type
OTHER